Anika Therapeutics (ANIK) Asset Utilization Ratio (2011 - 2026)

Anika Therapeutics (ANIK) has reported Asset Utilization Ratio for 16 consecutive years, with 0.67 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio rose 9.81% year-over-year to 0.67 in Q2 2026; TTM through Jun 2026 was 0.67, a 9.81% increase from a year earlier, with the FY2025 full-year figure at 0.57, up 13.33% from the prior year.
• Asset Utilization Ratio was 0.67 for Q2 2026 at Anika Therapeutics, up from 0.63 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.67 in Q2 2026 and troughed at 0.33 in Q4 2022.
• A 5-year average of 0.47 and a median of 0.43 in 2022 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio retreated 23.22% in 2023 and jumped 71.04% in 2025, its largest moves.
• Over 5 years, Asset Utilization Ratio stood at 0.33 in 2022, then climbed by 23.5% to 0.4 in 2023, then soared by 36.91% to 0.55 in 2024, then grew by 7.58% to 0.59 in 2025, then rose by 11.91% to 0.67 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.67 (Q2 2026), 0.63 (Q1 2026), and 0.59 (Q4 2025), per Business Quant data.